Home About

TL;DR CNBC


Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them - TL;DR CNBC

Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them

Publishing timestamp: 2023-11-30 10:32:50


Summary

The article discusses the slumping Covid vaccination rates in the US and the uncertainty surrounding future rates. It mentions that low vaccination rates put more people at risk of severe Covid infections and that combination shots targeting multiple respiratory viruses could potentially boost vaccination rates. However, there are also concerns about vaccine skepticism, lack of urgency, and the need for clear communication from public health officials to establish Covid vaccination as a routine part of healthcare.


Sentiment: MIXED

Tickers: MRNA,  PFE,  NVAX, 

Keywords: biotech and pharmaceuticals,  business news,  biotechnology,  business,  breaking news,  pharmaceuticals,  health care industry,  united states,  moderna inc,  pfizer inc,  novavax inc,  covid-19,  science, 

Source: https://www.cnbc.com/2023/11/30/us-covid-shot-rates-are-low-and-it-will-be-a-challenge-to-boost-them.html


Developed by Leo Phan